What is SRTAW's health score?

Strata Critical Medical, Inc. (SRTAW) has a TradeApes health score of 45 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is SRTAW's estimated fair value?

Based on our 5-year discounted cash flow model, Strata Critical Medical, Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is SRTAW undervalued or overvalued?

Our model currently rates SRTAW as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for SRTAW... Refresh in a moment for the full analysis.

Strata Critical Medical, Inc. (SRTAW)

Healthcare Overvalued Low mixed

Updated: 2026-04-21

TradeApes Score

hold

Financial Strength

45 Mixed

Operating Trend

45 Mixed

Relative Value

50 Mixed

Capital Allocation

20 Stressed

Risk

65 Healthy

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.